JP2024538615A5 - - Google Patents

Info

Publication number
JP2024538615A5
JP2024538615A5 JP2024519447A JP2024519447A JP2024538615A5 JP 2024538615 A5 JP2024538615 A5 JP 2024538615A5 JP 2024519447 A JP2024519447 A JP 2024519447A JP 2024519447 A JP2024519447 A JP 2024519447A JP 2024538615 A5 JP2024538615 A5 JP 2024538615A5
Authority
JP
Japan
Application number
JP2024519447A
Other languages
Japanese (ja)
Other versions
JPWO2023056369A5 (https=
JP2024538615A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077279 external-priority patent/WO2023056369A1/en
Publication of JP2024538615A publication Critical patent/JP2024538615A/ja
Publication of JP2024538615A5 publication Critical patent/JP2024538615A5/ja
Publication of JPWO2023056369A5 publication Critical patent/JPWO2023056369A5/ja
Pending legal-status Critical Current

Links

JP2024519447A 2021-09-29 2022-09-29 タウホスホペプチドコンジュゲートの安全な投与の方法 Pending JP2024538615A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163261793P 2021-09-29 2021-09-29
US63/261,793 2021-09-29
PCT/US2022/077279 WO2023056369A1 (en) 2021-09-29 2022-09-29 Method of safe administration of tau phosphopeptide conjugate

Publications (3)

Publication Number Publication Date
JP2024538615A JP2024538615A (ja) 2024-10-23
JP2024538615A5 true JP2024538615A5 (https=) 2025-10-09
JPWO2023056369A5 JPWO2023056369A5 (https=) 2025-10-09

Family

ID=85783654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024519447A Pending JP2024538615A (ja) 2021-09-29 2022-09-29 タウホスホペプチドコンジュゲートの安全な投与の方法

Country Status (9)

Country Link
US (1) US20250049900A1 (https=)
EP (1) EP4408864A4 (https=)
JP (1) JP2024538615A (https=)
KR (1) KR20240082368A (https=)
CN (1) CN118613496A (https=)
AU (1) AU2022356435A1 (https=)
CA (1) CA3233247A1 (https=)
MX (1) MX2024003775A (https=)
WO (1) WO2023056369A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ598356A (en) * 2009-07-30 2014-06-27 Pfizer Vaccines Llc Antigenic tau peptides and uses thereof
KR102710762B1 (ko) * 2017-10-25 2024-09-25 얀센 파마슈티칼즈, 인코포레이티드 인산화 타우 펩티드의 조성물 및 이의 용도
EA202192891A1 (ru) * 2019-04-24 2022-02-04 Янссен Фармасьютикалз, Инк. Гетерологичное введение анти-тау вакцин

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13150U (https=)
BY13159U (https=)
BY13140U (https=)
BY13135U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
BY13149U (https=)
BY13168U (https=)